![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 26, 24451-24461, July 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*






¶
From the
Department of Human Nutrition and Metabolism, Hebrew University Medical School, Ein-Kerem, P. O. Box 12272, Jerusalem 91120 and
Quark Biotech Inc., Weizmann Science Park, Ness Ziona 70400, Israel
Hepatocyte nuclear factor-4
(HNF-4
) activity is modulated by natural and xenobiotic fatty acid and fatty acyl-CoA ligands as a function of their chain length, unsaturation, and substitutions. The acyl-CoA site of HNF-4
is reported here to consist of the E-F domain, to bind long-chain acyl-CoAs but not the respective free acids, and to catalyze the hydrolysis of bound fatty acyl-CoAs. The free acid pocket, previously reported in the x-ray structure of HNF-4
E-domain, entraps fatty acids but excludes acyl-CoAs. The acyl-CoA and free acid sites are distinctive and noncongruent. Free fatty acid products of HNF-4
thioesterase may exchange with free acids entrapped in the fatty acid pocket of HNF-4
. Cross-talk between the acyl-CoA and free fatty acid binding sites is abrogated by high affinity, nonhydrolyzable acyl-CoA ligands of HNF-4
that inhibit its thioesterase activity. Hence, HNF-4
transcriptional activity is controlled by its two interrelated acyl ligands and two binding sites interphased in tandem by the thioesterase activity. The acyl-CoA/free-acid and receptor/enzyme duality of HNF-4
extends the paradigm of nuclear receptors.
Received for publication, January 20, 2005 , and in revised form, May 2, 2005.
* This work was supported in part by the US-Israeli Binational Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem 91120, Israel. Tel.: 972-2-675-8305; Fax: 972-2-643-1105; E-mail: bartanaj{at}cc.huji.ac.il.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Gates Goodyer, Z. Rhani, and H. Zheng Expression of the Hepatic Specific V1 Messenger Ribonucleic Acid of the Human Growth Hormone Receptor Gene Is Regulated by Hepatic Nuclear Factor (HNF)-4{alpha}2 and HNF-4{alpha}8 Mol. Endocrinol., February 1, 2008; 22(2): 485 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, B. Christian, and D. B. Jump Regulation of Rat Hepatic L-Pyruvate Kinase Promoter Composition and Activity by Glucose, n-3 Polyunsaturated Fatty Acids, and Peroxisome Proliferator-activated Receptor-{alpha} Agonist J. Biol. Chem., July 7, 2006; 281(27): 18351 - 18362. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jenkins, W. Yan, D. J. Mancuso, and R. W. Gross Highly Selective Hydrolysis of Fatty Acyl-CoAs by Calcium-independent Phospholipase A2beta: ENZYME AUTOACYLATION AND ACYL-CoA-MEDIATED REVERSAL OF CALMODULIN INHIBITION OF PHOSPHOLIPASE A2 ACTIVITY J. Biol. Chem., June 9, 2006; 281(23): 15615 - 15624. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |